Updated 7 August 2026, 9:15am ET. Oklo (NYSE: OKLO) traded at $44.05 in Friday pre-market, up 4.27% (RTTNews quote, 8:02am ET) after reporting its first-ever quarterly revenue before the open. Verdict: the revenue line arrived — $1.2 million — but it is rounding error against a $48.5 million quarterly loss, and the stock is defending the bottom of its 52-week range. The print does not settle the story; the Aurora regulatory calendar does.
Key facts from Oklo’s Q2 2026 report
- Revenue: $1.2 million, versus zero in Q2 2025 — the first revenue Oklo has ever reported (RTTNews).
- Net loss: $48.5 million, or $0.28 per share, versus a $24.7 million loss ($0.18 per share) a year earlier. The loss roughly doubled.
- That missed the street. Analysts had modelled a loss of about $0.16–$0.17 per share (TipRanks consensus ahead of the print).
- Operating expenses: $74.4 million, up from $28.01 million a year ago — the direct cause of the wider loss.
- The stock rose anyway, up 4.27% pre-market at $44.05, against a 52-week range of $44.88 to $193.84.
- Call: CEO Jacob DeWitte and CFO Craig Bealmear hosted an 8:30am ET business update, a date the company confirmed on 27 July.
The revenue number beat a very low bar — and it barely matters
Going into Friday, the consensus expectation was that Oklo would post roughly $91,000 of revenue: a symbolic first dollar, not a business. The actual figure, $1.2 million, is more than ten times that. On any other kind of company that would be the headline.
It is not the headline here, because the cost side moved far more. Operating expenses hit $74.4 million against $28.01 million a year ago — a $46 million increase, which is roughly 38 times the entire revenue line. The net loss widened to $48.5 million from $24.7 million. Oklo spent about $40 for every $1 it booked.
That is not, on its own, an indictment. Oklo is building fast-fission powerhouses, and a pre-commercial reactor developer is supposed to be consuming capital while it works through licensing. The relevant question for anyone holding the stock is not whether the loss is large — it is whether the spending is buying regulatory progress on schedule. On that, the quarter gave investors something concrete.
What actually advanced this quarter
Three operational items moved, and they matter more to the 2027 story than the income statement does:
- Aurora-INL — the flagship Idaho National Laboratory project continued to advance. This is the unit that has to prove the design works in the field.
- NRC approval of the Principal Design Criteria topical report — a genuine regulatory milestone. Getting design criteria blessed early removes a category of licensing risk that has historically buried advanced-reactor developers.
- Aurora-Ohio — Oklo filed PJM interconnection applications for a planned 1.2-gigawatt campus. Interconnection queue position is one of the scarcest assets in US power right now, and it is the clearest tie between Oklo and the data-centre demand story.
That last point is the actual investment thesis. Oklo’s pitch is not “a nuclear startup” — it is dedicated generation for AI data centres at a moment when the constraint on compute has moved from chips to power. We covered the balance-sheet side of that build-out in our look at the AI data-centre bear case and its $99bn backlog against $50bn of debt.
Why the stock went up on a wider loss
Shares rose 4.27% pre-market despite a per-share loss roughly 65% worse than consensus. Three plausible reasons, in order of how much weight we would give them:
1. Expectations were already on the floor. At $44.05, Oklo trades about 77% below its $193.84 52-week high. The de-rating already happened. A bad quarter from a stock priced for a bad quarter is not new information.
2. The loss is spending, not impairment. The miss came from operating expenses tied to project execution, not from a writedown or a lost contract. Markets treat those very differently.
3. Revenue exists now. Crossing from zero to a real number changes how the company can be modelled, even at $1.2 million.
The caution: pre-market moves on thin volume routinely reverse once the regular session absorbs the full release and the call commentary. Treat the 4.27% as a first reaction, not a verdict.
Scenarios: where the street actually sits
Analyst targets on Oklo are unusually dispersed, which is what happens when a company’s value depends on binary regulatory outcomes. We are showing the real range rather than a tidy one, with each level tied to a named source.
| Scenario | Level | Anchor |
|---|---|---|
| Bear | $14 | The lowest of 25 analyst targets polled by S&P Global — roughly 68% below Friday’s $44.05. The case: cash burn at $74.4m of quarterly opex against pre-commercial revenue, with Aurora slipping. |
| Base | $55–$76 | $55 is the low target in a separate 22-analyst poll; $76 is Barclays’ target after Christine Cho cut it from $82 while keeping a Buy. Implies 25%–73% upside from spot. |
| Bull | $87 | $86.95 is the 25-analyst average target (S&P Global), with the street high at $140. Requires Aurora-INL delivering and the Ohio interconnection converting to contracted load. |
Note the asymmetry the table exposes: the average street target sits nearly 100% above the current price, yet the stock is pinned at the bottom of its 52-week range. Either the analysts are slow to mark down, or the market is pricing a regulatory failure the analysts are not. Both have been true of this name at different points in the last year.
Quick Take
Oklo’s first revenue is real but immaterial at $1.2m. The loss doubling to $48.5m is the number that describes the business today, and it missed consensus badly. What justifies owning it is not this quarter’s P&L — it is the NRC design-criteria approval and the 1.2GW Ohio interconnection filing, both of which are steps toward selling power to data centres. What kills it is Aurora slipping while $74m a quarter goes out the door. The pre-market pop is the market saying the spending was expected; it is not the market saying the plan is de-risked.
How this compares with the rest of the small-reactor trade
Oklo is not the only listed bet on advanced nuclear, and the group tends to move together on policy news rather than on individual results. NuScale is the closest comparable in the small modular reactor space — we laid out its range in our NuScale SMR bull and bear case. For Oklo’s longer-horizon scenario framing beyond this quarter’s print, our standing Oklo $140 bull case versus $14 bear case analysis covers the full path.
What to watch next
- Final DOE approval for Aurora — the single most-cited near-term catalyst on the analyst side.
- Cash runway disclosure — at roughly $48.5m of quarterly net loss, the financing question is a matter of when, and dilution is the mechanism.
- PJM interconnection progress in Ohio — queue position converting into an actual energisation date.
- Whether the pre-market gain holds through Friday’s regular session.
Frequently asked questions
Did Oklo beat or miss expectations in Q2 2026?
Both, on different lines. Revenue of $1.2 million came in well above the roughly $91,000 the street had modelled. But the net loss of $0.28 per share was materially worse than the $0.16–$0.17 loss analysts expected.
How much revenue did Oklo actually report?
$1.2 million for Q2 2026, against zero in the same quarter of 2025. It is the first revenue in the company’s history as a public company.
Why did Oklo stock rise if the loss got bigger?
The stock had already fallen about 77% from its 52-week high, so a weak quarter was largely priced in. The wider loss also came from operating spending on project execution rather than from an impairment or a lost contract, which markets penalise less.
What is Oklo’s current share price?
$44.05 in pre-market trading on Friday 7 August 2026, up 4.27%, per an RTTNews quote timestamped 8:02am ET. The 52-week range runs from $44.88 to $193.84, putting the stock at the very bottom of that band.
What do analysts think Oklo is worth?
The average target across 25 analysts polled by S&P Global is $86.95, with a low of $14 and a high of $140. Barclays’ Christine Cho holds a Buy with a $76 target, cut from $82.
What is the Aurora powerhouse?
Aurora is Oklo’s compact fast-fission reactor design, intended to supply clean, scalable electricity — with data centres as the target customer. Aurora-INL at Idaho National Laboratory is the lead project; Aurora-Ohio is a planned 1.2-gigawatt campus now in the PJM interconnection queue.
Is Oklo profitable?
No. Oklo lost $48.5 million in Q2 2026 alone, with operating expenses of $74.4 million against $1.2 million of revenue. It is a pre-commercial company funding reactor development and licensing.
Sources: Oklo Q2 2026 results via RTTNews; consensus estimates and analyst ratings via TipRanks, S&P Global and Benzinga; company earnings-date announcement 27 July 2026.
This article is for informational purposes only and does not constitute financial advice. FinanceFeeds does not recommend buying, selling or holding any security. Figures are accurate as of the timestamps stated and market prices move quickly. Always do your own research and consider consulting a licensed financial adviser before making investment decisions.